Manning Ventures Inc
CNSX:MANN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Manning Ventures Inc
CNSX:MANN
|
CA |
|
Limoneira Co
NASDAQ:LMNR
|
US |
|
S
|
SynAct Pharma AB
STO:SYNACT
|
SE |
|
J
|
JFB Construction Holdings
NASDAQ:JFB
|
US |
|
IG Design Group PLC
LSE:IGR
|
UK |
|
M
|
Mercurius Capital Investment Ltd
SGX:5RF
|
SG |
|
Shan Dong Lubei Chemical Co Ltd
SSE:600727
|
CN |
|
H
|
Hugo Boss AG
OTC:BOSSY
|
DE |
|
Caica Digital Inc
TSE:2315
|
JP |
|
J Smart & Co (Contractors) PLC
LSE:SMJ
|
UK |
|
Rocket Lab USA Inc
NASDAQ:RKLB
|
US |
|
abrdn European Logistics Income PLC
LSE:ASLI
|
UK |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
Vmoto Ltd
ASX:VMT
|
AU |
|
Global Payments Inc
NYSE:GPN
|
US |
|
Shree Rama Multi-Tech Ltd
NSE:SHREERAMA
|
IN |
|
T
|
THC Farmaceuticals Inc
OTC:CBDG
|
US |
|
G
|
Gulshan Polyols Ltd
NSE:GULPOLY
|
IN |
|
P
|
Pelayaran Nelly Dwi Putri Tbk PT
IDX:NELY
|
ID |
Income Statement
Earnings Waterfall
Manning Ventures Inc
Income Statement
Manning Ventures Inc
| Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(9)
|
(9)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(7)
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-780%
|
(1)
-696%
|
(1)
-49%
|
(2)
-6%
|
(2)
-4%
|
(1)
+28%
|
(1)
+35%
|
(1)
-13%
|
(1)
+8%
|
(1)
-56%
|
(1)
0%
|
(1)
-11%
|
(2)
-17%
|
(2)
-5%
|
(2)
-1%
|
(2)
-5%
|
(1)
+41%
|
(9)
-727%
|
(9)
+2%
|
(1)
+85%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
(7)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
+17%
|
(1)
-704%
|
(1)
-20%
|
(1)
-6%
|
(2)
-41%
|
(1)
+33%
|
(1)
-2%
|
(1)
+1%
|
(1)
+15%
|
(1)
-22%
|
(1)
0%
|
(1)
-15%
|
(2)
-56%
|
(2)
+9%
|
(2)
-1%
|
(2)
-2%
|
(8)
-299%
|
(9)
-8%
|
(9)
+1%
|
(8)
+3%
|
|
| Net Income | ||||||||||||||||||||||
| Income from Continuing Operations |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(8)
|
(9)
|
(9)
|
(8)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
+17%
|
(1)
-704%
|
(1)
-20%
|
(1)
-6%
|
(2)
-41%
|
(1)
+33%
|
(1)
-2%
|
(1)
+1%
|
(1)
+15%
|
(1)
-22%
|
(1)
0%
|
(1)
-15%
|
(2)
-56%
|
(2)
+9%
|
(2)
-1%
|
(2)
-2%
|
(8)
-299%
|
(9)
-8%
|
(9)
+1%
|
(8)
+3%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.03
-200%
|
-0.05
-67%
|
-0.05
N/A
|
-0.02
+60%
|
-0.18
-800%
|
-0.03
+83%
|
-0.03
N/A
|
-0.03
N/A
|
-0.06
-100%
|
-0.05
+17%
|
-0.06
-20%
|
-0.07
-17%
|
-0.09
-29%
|
-0.08
+11%
|
-0.07
+12%
|
-0.07
N/A
|
-0.24
-243%
|
-0.26
-8%
|
-0.26
N/A
|
-0.25
+4%
|
|